United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE346.1900
- TODAY'S CHANGE (%)3.7300 (1.0892%)
- Bid / Lots316.0000/ 1
- Ask / Lots356.0000/ 2
- Open / Previous Close343.0000 / 342.4600
- Day Range
- 52 Week Range
- Volume417,593
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 2921 | 341.86 |
| 09:34 ET | 200 | 341.86 |
| 09:36 ET | 761 | 340.9 |
| 09:38 ET | 500 | 340 |
| 09:39 ET | 560 | 341 |
| 09:41 ET | 366 | 340.83 |
| 09:43 ET | 890 | 343 |
| 09:45 ET | 14577 | 341.96 |
| 09:48 ET | 100 | 342.025 |
| 09:50 ET | 500 | 342.475 |
| 09:52 ET | 431 | 342.63 |
| 09:54 ET | 1625 | 342.48 |
| 09:56 ET | 1037 | 341.94 |
| 09:57 ET | 200 | 341.11 |
| 09:59 ET | 300 | 341.12 |
| 10:03 ET | 357 | 341.1 |
| 10:12 ET | 200 | 341.12 |
| 10:14 ET | 4697 | 340.66 |
| 10:15 ET | 400 | 341.32 |
| 10:17 ET | 100 | 340.93 |
| 10:19 ET | 600 | 340.815 |
| 10:21 ET | 225 | 340.8751 |
| 10:24 ET | 500 | 340.53 |
| 10:26 ET | 200 | 340.255 |
| 10:28 ET | 1500 | 340.81 |
| 10:30 ET | 700 | 340.96 |
| 10:32 ET | 1798 | 340.36 |
| 10:33 ET | 259 | 340.82 |
| 10:35 ET | 300 | 341.5 |
| 10:37 ET | 886 | 341.1 |
| 10:39 ET | 300 | 341.2 |
| 10:44 ET | 15980 | 341.29 |
| 10:46 ET | 750 | 341.61 |
| 10:48 ET | 645 | 341.85 |
| 10:50 ET | 384 | 341.73 |
| 10:51 ET | 308 | 341.955 |
| 10:55 ET | 100 | 342.17 |
| 10:57 ET | 1059 | 341.86 |
| 11:00 ET | 616 | 342.54 |
| 11:02 ET | 300 | 342.5 |
| 11:04 ET | 100 | 342.425 |
| 11:06 ET | 725 | 342.46 |
| 11:08 ET | 600 | 342.87 |
| 11:11 ET | 116 | 342.75 |
| 11:15 ET | 100 | 342.75 |
| 11:20 ET | 400 | 343.15 |
| 11:22 ET | 100 | 343.44 |
| 11:24 ET | 4230 | 343.665 |
| 11:26 ET | 300 | 343.52 |
| 11:27 ET | 1947 | 343.875 |
| 11:29 ET | 600 | 343.89 |
| 11:33 ET | 700 | 344.11 |
| 11:36 ET | 400 | 343.825 |
| 11:38 ET | 600 | 344.46 |
| 11:42 ET | 444 | 344.4 |
| 11:45 ET | 143 | 344.765 |
| 11:49 ET | 625 | 345.085 |
| 11:51 ET | 1702 | 344.93 |
| 11:54 ET | 682 | 344.17 |
| 11:56 ET | 200 | 344.03 |
| 11:58 ET | 200 | 343.63 |
| 12:00 ET | 500 | 343.94 |
| 12:02 ET | 100 | 343.945 |
| 12:05 ET | 923 | 344.345 |
| 12:07 ET | 600 | 344.78 |
| 12:12 ET | 1683 | 344.41 |
| 12:14 ET | 100 | 344.32 |
| 12:20 ET | 100 | 344.32 |
| 12:23 ET | 100 | 344.34 |
| 12:25 ET | 300 | 344.2928 |
| 12:27 ET | 2575 | 344.78 |
| 12:30 ET | 400 | 344.5 |
| 12:32 ET | 100 | 344.7925 |
| 12:34 ET | 605 | 344.92 |
| 12:36 ET | 100 | 345.24 |
| 12:38 ET | 800 | 345.41 |
| 12:41 ET | 200 | 345.525 |
| 12:43 ET | 200 | 345.675 |
| 12:45 ET | 931 | 345.71 |
| 12:48 ET | 722 | 345.53 |
| 12:52 ET | 300 | 345.732 |
| 12:54 ET | 700 | 346.24 |
| 12:56 ET | 100 | 346.355 |
| 12:57 ET | 256 | 346.29 |
| 12:59 ET | 700 | 346.125 |
| 01:01 ET | 100 | 346.04 |
| 01:06 ET | 100 | 346.04 |
| 01:10 ET | 578 | 346.13 |
| 01:19 ET | 500 | 346.57 |
| 01:26 ET | 1162 | 346.02 |
| 01:28 ET | 212 | 346.195 |
| 01:30 ET | 101 | 346.075 |
| 01:33 ET | 318 | 345.95 |
| 01:35 ET | 100 | 346.19 |
| 01:42 ET | 373 | 346.03 |
| 01:44 ET | 897 | 345.96 |
| 01:48 ET | 200 | 345.9 |
| 01:50 ET | 1413 | 346.04 |
| 01:53 ET | 1500 | 345.59 |
| 01:55 ET | 542 | 345.87 |
| 01:57 ET | 592 | 345.9192 |
| 02:02 ET | 100 | 345.69 |
| 02:04 ET | 100 | 345.54 |
| 02:06 ET | 100 | 345.69 |
| 02:09 ET | 1800 | 345.53 |
| 02:11 ET | 400 | 345.02 |
| 02:18 ET | 250 | 345.2 |
| 02:20 ET | 100 | 345.195 |
| 02:22 ET | 1000 | 345 |
| 02:24 ET | 5305 | 346.3 |
| 02:26 ET | 700 | 346.26 |
| 02:31 ET | 425 | 346.18 |
| 02:33 ET | 200 | 346.45 |
| 02:36 ET | 100 | 346.45 |
| 02:38 ET | 1575 | 346.045 |
| 02:40 ET | 200 | 346.085 |
| 02:42 ET | 100 | 346.22 |
| 02:44 ET | 1100 | 347.21 |
| 02:47 ET | 903 | 346.7 |
| 02:49 ET | 450 | 346.61 |
| 02:51 ET | 200 | 346.49 |
| 02:54 ET | 200 | 346.49 |
| 02:56 ET | 344 | 345.98 |
| 02:58 ET | 704 | 346.425 |
| 03:00 ET | 820 | 345.7 |
| 03:02 ET | 400 | 345.6 |
| 03:07 ET | 1114 | 345.5 |
| 03:09 ET | 300 | 345.27 |
| 03:12 ET | 500 | 345.4 |
| 03:14 ET | 200 | 345.13 |
| 03:16 ET | 300 | 345.15 |
| 03:18 ET | 2300 | 345.69 |
| 03:20 ET | 400 | 345.665 |
| 03:21 ET | 100 | 345.66 |
| 03:23 ET | 600 | 345.44 |
| 03:25 ET | 200 | 345.44 |
| 03:27 ET | 790 | 345.38 |
| 03:30 ET | 100 | 345.555 |
| 03:32 ET | 250 | 345.63 |
| 03:34 ET | 3392 | 345.85 |
| 03:36 ET | 800 | 345.82 |
| 03:38 ET | 4829 | 346.14 |
| 03:39 ET | 300 | 345.85 |
| 03:41 ET | 2000 | 345.595 |
| 03:43 ET | 1440 | 345.92 |
| 03:45 ET | 600 | 345.955 |
| 03:48 ET | 2895 | 345.975 |
| 03:50 ET | 2606 | 346.22 |
| 03:52 ET | 2740 | 346.035 |
| 03:54 ET | 910 | 346.26 |
| 03:56 ET | 5732 | 345.4 |
| 03:57 ET | 3898 | 346.1 |
| 03:59 ET | 70337 | 346.19 |
Yesterday
Aug 28, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:08AM ET on Wednesday Aug 28, 2024 by Dow Jones
9:08AM ET on Wednesday Aug 28, 2024 by Dow JonesUnited Therapeutics Corporation to Present at Upcoming Investor Conferences, from 7:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
7:00AM ET on Wednesday Aug 28, 2024 by Dow Jones
Aug 20, 2024
DJ United Therapeutics Is Maintained at Overweight by Wells Fargo, from 12:31PM ET on Tuesday Aug 20, 2024 by Dow Jones
12:31PM ET on Tuesday Aug 20, 2024 by Dow Jones
Aug 19, 2024
DJ S&P 500 Futures Steady In Premarket Trading; United Therapeutics, Tempus AI Lead, from 7:30AM ET on Monday Aug 19, 2024 by Dow Jones
7:30AM ET on Monday Aug 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 15.2B | 15.9x | +8.22% |
Biomarin Pharmaceutical Inc | 16.2B | 63.9x | --- |
Exact Sciences Corp | 10.8B | -66.7x | --- |
Neurocrine Biosciences Inc | 12.0B | 36.7x | +62.04% |
Beigene Ltd | 21.3B | -41.6x | --- |
Qiagen NV | 10.3B | 144.1x | +12.66% |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.2B |
|---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.59 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 15.9x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | 13.5x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
